4//SEC Filing
KOENIG DAVID 4
Accession 0001179110-11-002329
CIK 0001222244other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 10:45 AM ET
Size
12.1 KB
Accession
0001179110-11-002329
Insider Transaction Report
Form 4
KOENIG DAVID
Director
Transactions
- Award
Common stock, $0.00001 par value
2011-02-08$1.01/sh+2,476$2,501→ 135,910 total
Holdings
- 50,000
Warrants
Exercise: $1.30Exp: 2013-08-02→ Common stock, $0.00001 par value (50,000 underlying) - 14,535
Stock Options
Exercise: $1.72Exp: 2017-08-10→ Common stock, $0.00001 par value (14,535 underlying) - 1,875(indirect: Shares held by Clinical Network Management Corp., of which reporting person is a managing officer.)
Common Stock, $0.00001 par value
- 26,571(indirect: Shares held by Clinical Network Inc., of which the reporting person is a managing officer.)
Common Stock, $0.00001 par value
- 3,000
Stock Options
Exercise: $11.33Exp: 2012-04-19→ Common Stock, $0.00001 par value (3,000 underlying) - 50,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (50,000 underlying)
Footnotes (3)
- [F1]Currently exercisable.
- [F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
- [F3]Shares issued in lieu of cash for directors' fees as approved by the issuer's Board of Directors, which are exempt under Section 16b-3(d).
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001285927
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 10:45 AM ET
- Size
- 12.1 KB